Blind Veterans Study P2

Part 2 Sleep and Circadian Monitoring Study  Please note, Part 2 of the study is temporarily suspended in line with current public health guidelines. Participants who may be eligible for Part 2 will be contacted in due course. Thank you for your understanding and...

Blind Veterans Study

Circadian Therapeutics Sleep Health Survey In partnership with the Blind Veterans UK, Circadian Therapeutics is running a survey to identify sleep and circadian disruption experienced by vision impaired individuals in order to provide informed feedback to the Visually...
Collaboration with Blind Veterans UK

Collaboration with Blind Veterans UK

Collaboration with Blind Veterans UK The launch of our exciting research collaboration with the Blind Veterans UK Charity. Nigel Jones, Managing Director and COO of Circadian Therapeutics (CT) is pictured signing the research collaboration agreement with Major General...

CT1500 Phase 1 Study

CT1500 Phase 1 Study CT1500 Phase 1 Study Circadian Therapeutics announces the first subject recruited to Phase I study for CT-1500, marks move to a clinical stage company • First subject dosed for Phase I study• CT-1500 being developed to treat Non-24 Sleep-Wake...

BV PIS

Participant Information Sheet (PIS)   Blind Veterans and Circadian Therapeutics Sleep Health Study   Protocol Version: 2.2   Protocol Date: 20 August 2019   IRAS ID number: 248419   You are invited to take part in this research study. Please...